Company profileAs well as delivering pathology services and in line with the NHS’s own clinical vision and strategy, SYNLAB will be responsible for transforming existing hospital-based laboratory and diagnostic services into an integrated ’hub and spoke’ pathology network in south east London by 2024.
A state-of-the-art ’hub’ laboratory is being developed at Friars Bridge Court, in Blackfriars Road, London, providing access to improved services and equipment for routine and some specialist testing. On-site hospital laboratories will be turned into essential services laboratories (the spokes), focusing on the rapid turnaround of urgent tests, such as those needed for A&E departments. The hub will become one of the largest, purpose-built pathology laboratories in the UK.
The NHS will also benefit from SYNLAB’s global laboratory and diagnostic network, which will provide access to a wide range of clinical, scientific and operational expertise, as well as innovative research and development on an international scale. This has proven to be extremely valuable in SYNLAB’s existing partnerships with the NHS, particularly during the COVID-19 pandemic where UK access to supplies was critical, and where knowledge of how SYNLAB’s diagnostic testing services had responded elsewhere in Europe helped to inform and strengthen our own response here in the UK.
